What do you suppose is the going rate for convenience? If you ask pharmaceutical giant and AIDS profiteer Gilead Sciences, the rate for an HIV+ person is somewhere around $29,000. The FDA announced yesterday, amid the media din accompanying the… Read More ›
Atripla
A Cure or Some Cash?
There is always a point in researching any highly specialized subject when the documents you are reading stop being written in English. It doesn’t matter what the field is—biomedical research, law, literary criticism—there is a line in the sand that… Read More ›
The Color of Drug Money: Gilead Sciences and “Philanthropy”
By Drew Gibson Last night, while trudging through the endless cavalcade of reality shows on the TV guide, I came across a station that was playing The Gangs of New York. Naturally, I had to stop and watch it as… Read More ›